EC Seeks To Provide More Drug Information But Not Through DTC Ads
Executive Summary
The European Commission intends to propose regulatory changes aimed at ensuring that patients have greater access to non-biased information on medications
You may also be interested in...
PhRMA Weighs In On European Consumer Drug Information Proposal
Supporting a proposed European policy change permitting manufacturers to provide more drug information to the public, the Pharmaceutical Research and Manufacturers of America suggests that permissible information could include ongoing clinical research and disease management data not contained in approved product summaries
PhRMA Weighs In On European Consumer Drug Information Proposal
Supporting a proposed European policy change permitting manufacturers to provide more drug information to the public, the Pharmaceutical Research and Manufacturers of America suggests that permissible information could include ongoing clinical research and disease management data not contained in approved product summaries
FDA’s DTC Pre-Review Authority Will Face Court Challenge, Lawyers Predict
FDA authority to require pre-review of direct-to-consumer television ads "likely will be tested at some point in the courts," David Ogden of WilmerHale predicted during an Oct. 31 audioconference on the FDA Amendments Act